Next Article in Journal
Strong Affinity of Triazolium-Appended Dipyrromethenes (TADs) for BF4−
Next Article in Special Issue
Muscari comosum L. Bulb Extracts Modulate Oxidative Stress and Redox Signaling in HepG2 Cells
Previous Article in Journal
Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid
Previous Article in Special Issue
Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 25
Issue 19
10.3390/molecules25194554
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of Resveratrol in Mammalian Reproduction

by
Rolando Pasquariello
1,
Nicole Verdile
1,
Tiziana A. L. Brevini
2,
Fulvio Gandolfi
1,*,
Cristiano Boiti
3,
Massimo Zerani
3,* and
Margherita Maranesi
3
1
Department of Agricultural and Environmental Sciences, University of Milan, 20133 Milano, Italy
2
Department of Health, Animal Science and Food Safety, University of Milan, 20133 Milano, Italy
3
Department of Veterinary Medicine, University of Perugia, 06126 Perugia, Italy
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(19), 4554; https://doi.org/10.3390/molecules25194554
Submission received: 31 August 2020 / Revised: 20 September 2020 / Accepted: 30 September 2020 / Published: 5 October 2020
(This article belongs to the Special Issue Natural Compounds for Treatment and Prevention of Diabetes, Inflammation, Oxidative Stress and Reproductive Diseases)
Browse Figures
Versions Notes

Abstract

:
Resveratrol is one of the most investigated natural polyphenolic compounds and is contained in more than 70 types of plants and in red wine. The widespread interest in this polyphenol derives from its antioxidant, anti-inflammatory and anti-aging properties. Several studies have established that resveratrol regulates animal reproduction. However, the mechanisms of action and the potential therapeutic effects are still unclear. This review aims to clarify the role of resveratrol in male and female reproductive functions, with a focus on animals of veterinary interest. In females, resveratrol has been considered as a phytoestrogen due to its capacity to modulate ovarian function and steroidogenesis via sirtuins, SIRT1 in particular. Resveratrol has also been used to enhance aged oocyte quality and as a gametes cryo-protectant with mainly antioxidant and anti-apoptotic effects. In males, resveratrol enhances testes function and spermatogenesis through activation of the AMPK pathway. Furthermore, resveratrol has been supplemented to semen extenders, improving the preservation of sperm quality. In conclusion, resveratrol has potentially beneficial effects for ameliorating ovarian and testes function.

1. Introduction

Resveratrol (3,5,4′-trihydroxystilbene) is a polyphenol that belongs to dietary stilbenes, a class of natural compounds that display significant biological activities of medicinal interest. This compound is one of the best known and most investigated polyphenols found in nature, is produced by more than 70 different types of plants, and is contained in red wine and in several botanical extracts [1]. The importance of resveratrol in medicine has been known since the 1940s; it was, in fact, initially extracted from plant roots and successfully used in traditional Japanese and Chinese medicine [2,3]. Resveratrol derives from phenylalanine through the activation of the enzyme stilbene synthase and exists in two isomeric forms, trans- and cis- resveratrol [4] (Figure 1). Trans-resveratrol is the most common form in plants and the most widely investigated; therefore, in the present review, we will mainly deal with this isoform. Plants synthesize resveratrol and other stilbenes in response to stressful conditions including ultraviolet irradiation, extreme temperatures, mechanical damages, and the activity of microorganisms such as fungi and bacteria [5].
Therefore, this phenolic compound was initially characterized as a phytoalexin for its fungicidal role [6], and only later was it appreciated as a nutrient supplement, for several beneficial effects in the prevention and improvement of various diseases highlighted over the years [7]. Resveratrol is often associated with the “French paradox”, a term coined in the early 90s, based on epidemiological data from French people having a low incidence of coronary pathologies and generally a long life expectancy likely due to moderate consumption of red wine despite a diet characterized by high saturated fat intake [8]. Since its discovery, resveratrol has been considered to be effective in improving health and preventing chronic disorders, like ischemic and atherosclerotic injuries, neurodegenerative diseases, and metabolic diseases (e.g., diabetes) [7], thanks to its anti-inflammatory and antioxidant effects [9]. The antioxidative effects of resveratrol are related to the high redox property of phenolic hydroxyl groups, which act as free radical scavengers. Resveratrol activates many antioxidant enzymes such as catalase and superoxide dismutase [10].
Excellent and exhaustive reviews on the role of resveratrol on pregnancy [11], on the ovarian and endometrial function [12,13,14], and on the androgenic production of Leydig cells [15] have been published. This review aims to summarize the available data on the possible role of resveratrol on reproduction, with a particular focus on animals of veterinary interest. In particular, it will clarify the effect of resveratrol on both female and male reproduction and discuss the mechanisms of action.

2. Resveratrol Effects on Females

2.1. Resveratrol as a Phytoestrogen

Despite numerous studies, it is still debated whether resveratrol can be used alone or in combination with other estrogenic substances to regulate the reproductive function of animals or be used in estrogen replacement therapy of women [13,14]. With this aim, many authors have investigated the mechanism of action of resveratrol in different target organs in vitro [16,17] and in vivo [18].
Because resveratrol has a chemical structure similar to that of some estrogens, such as diethylstilbestrol (DES), it is considered a natural phytoestrogen [16,17]. The cardioprotective activity [19] and estrogen-dependent cancer protection role of estrogens [20,21] are well-documented. Numerous studies have described the same estrogenic role of resveratrol in these disorders [22,23,24,25,26].
Estrogens, including phytoestrogens, act via the estrogen receptors (ERs), members of the nuclear receptor superfamily. Many chemicals of plant origin such as genistein, coumestrol, and resveratrol contain one or two six-carbon rings with hydroxyl substituents that can mimic estradiol; therefore, such a phytochemical compound is an agonist for the two receptor subtypes, ER alpha and ER beta [27]. The transcription is activated at the same nuclear level for both estrogen and phytochemical compounds, in the peculiar tract of the estrogen response element [16].
Since 1997, Gehm et al. [17], using different assays, demonstrated that resveratrol is a phytoestrogen that acts via binding to ERs and has different agonist possibilities dependent on the system in which it is assayed. Stahl et al. [28] described positive estrogenic effects of different phytoestrogenic compounds such as genistein, coumestrol, and zearalenone on estrogen-dependent pituitary tumor cells. By Western blot, the authors found only the ER alpha expression in this cell line, supposing that these phytoestrogen responses were mediated by this isoform [28]. Conversely, resveratrol did not bind and had no subsequent growth activity in the same cell lines, despite it inducing prolactin secretion and mRNA up-regulation, and both effects were blocked by estrogen antagonists. In these cell lines, resveratrol probably acts independently of the binding to ER alpha, but, in any case, it shows an effect comparable to that of other tested phytoestrogens [28].
In 2002, Henry et al. [18] examined the effect of resveratrol administered to female rats in vivo. Although resveratrol did not show high affinity for ERs, it was still able to determine effects on hypothalamic–pituitary–gonadal axis regulatory genes, affecting the estrous cycles and inducing gonad hypertrophy in intact animals. Instead, resveratrol did not replace the effect induced by 17-beta estradiol in rat gonadectomized females [18].
In Chinese Hamster Ovary cells (CHO-K1) it was found that resveratrol binds the two ER receptors (ER alpha and beta) with a similar affinity, but with an affinity approximately 7,000 times lower than estradiol [16]. This is in contrast with findings obtained for other phytoestrogens, which bind the beta form of ERs with higher affinity than the alpha form [29]. Interestingly, also DES, which has a structural analogy with resveratrol [17], shows a greater affinity for the alpha form of the ERs [29].
Although there are conflicting data regarding resveratrol as an agonist of ERs, the findings testify to a potential role of this compound in enhancing the estrogenic effects of hormones and therefore as a modulator of the reproductive function.

2.2. Mechanisms of Action: Sirtuins

Growing evidences indicate the role of resveratrol in ovarian function and steroidogenesis modulation mediated by sirtuins [12,14] (Figure 2).
Sirtuins are proteins of the nicotinamide adeninedinucleotide-dependent deacetylases family (or silent information regulator 2 family—SIRT family), which are well-known for their role in many cellular processes [30] such as apoptosis [31], cell reprogramming [32], and DNA repair [33]. Sirtuins are also involved in cancer progression [34], ovarian aging [35,36], redox homeostasis [37], and glucose and lipid metabolism [38]. Since modification of the NAD+/NADH ratio controls the activity of SIRTs, all members of this family have a pivotal role in sensing the oxidative stress and energetic condition of the cell [39].
To date, seven members of the sirtuin family have been identified in mammals (SIRT1-7), each member playing a role in ovarian function (for an extensive review, see [39,40]). In fact, damage impairing SIRT’s activity leads to fertility deficits [39,41,42].
Resveratrol is the most potent natural ligand of silent information regulator 2 type 1 (SIRT1). After a stressful event, SIRT1 is activated and binds different molecular targets, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), tumor protein p53, forkhead box (FOX) -O1 (FOXO1), -O3 (FOXO3), and -O4 (FOXO4), peroxisome proliferator-activated receptor-gamma coactivator (PGC-1 alpha), liver X receptor, nibrin (NBS1), and hypoxia-inducible factor 2 alpha (HIF-2 alpha) (Figure 2) [43,44,45]. By activating these molecules, via SIRT1, resveratrol has a pivotal role in regulating energy homeostasis, gene silencing, genomic stability, and cell survival (Figure 2) [43].
Resveratrol may also protect against ovarian aging through SIRT1-related cellular mechanisms, exerting an anti-oxidative effect that guards oocytes from age-dependent deficits [39].
In rat granulosa cells, resveratrol induced a transcript up-regulation of SIRT1, LH receptor, StAR, and P450 aromatase, while mRNA levels of FSH receptor remained unchanged [46], thus suggesting that resveratrol and SIRT1 can modulate ovarian functions via folliculogenesis-related molecules and gonadotropin receptor activation.
In swine granulosa cells, resveratrol increased SIRT1 mRNA and protein level in a dose-dependent fashion, accelerating cell apoptotic rate and follicular atresia [47]. Resveratrol supplemented in cultured porcine ovarian granulosa cells determined SIRT1 protein increase and apoptosis, promoting testosterone and estrogen release, while inhibiting cell proliferation [42].
When supplemented to in vitro maturation (IVM) medium, polydatin, a glycosidic form of resveratrol, improved embryo development, increasing SIRT1 protein and decreasing reactive oxygen species (ROS) [48]. In the same work, embryo protein levels of nuclear factor NF-kB and cyclooxygenase (COX2) were significantly lower when polydatin was added to the culture medium [48]. Since NFkB and especially COX2 play a pivotal role in inflammation, the authors supposed that this resveratrol analogue (polydatin) might have a beneficial effect on embryo development by decreasing their expression, thereby reducing any inflammatory processes in progress [48]. Using immunofluorescence and Western blot techniques, Wang et al. [49] evidenced the presence of SIRT1 in bovine granulosa cells, cumulus cells, oocytes, and blastocysts. Moreover, resveratrol increased SIRT1 mRNA and protein levels in cumulus cells [49]. These authors suggested that the beneficial effects of resveratrol on oocyte maturation and embryonic development after in vitro fertilization might be SIRT1-mediated [49].
Thus, there is enough evidence that resveratrol may have a positive effect on the reproductive function via sirtuins and specifically via SIRT1 even if the possibility that resveratrol acts through other pathways cannot be excluded.

2.3. Effects of Resveratrol on Oocyte and Embryo

Resveratrol interferes with the endocrine and paracrine communications taking place between the cumulus oophorous and the oocyte. In domestic species, it is well documented that resveratrol: enhances maturation and quality of aged oocytes [50], is an effective cryo-protectant with antioxidant and anti-apoptotic effects [51], and increases the embryo developmental competence to the blastocyst stage [52].

2.3.1. Oocyte Maturation

Phytomelatonin is a well-known product used in phytomedicine for its antioxidant properties [53]. In this context, Lee et al. [54] investigated the synergistic properties of melatonin and resveratrol to ameliorate porcine IVM of oocytes. These authors found that the association of the two compounds in the medium of cumulus-oocyte complexes undergoing IVM supported a synergistic increase in oocyte nuclear maturation and total cell numbers of parthenogenetic activated blastocysts, and improved the development of somatic cell nuclear transfer embryos [54]. In another study, in cattle, supplementation of IVM medium with different antioxidants, including resveratrol, was correlated with decreased ROS levels and increased GSH levels in the oocytes [55]. Similarly, supplementation with 20 µM of resveratrol improved the quality of bovine oocyte, which matured in vitro by ameliorating mitochondrial quantity and quality, ATP content, and fertilization rate, via SIRT1 up-regulation [56].

2.3.2. Oocyte Cryopreservation

Cat immature oocytes contain a large-sized germinal vesicle with decondensed chromatin that is highly susceptible to cryo-damage [51]. The histone deacetylase enhancer activity of resveratrol prevents cryopreservation damage during oocytes vitrification [57]. Comizzoli et al. examined the use of resveratrol as an adjuvant in cryopreservation, revealing that transient epigenetic modifications associated with chromatin compaction of germinal vesicle induced by resveratrol were fully reversible and beneficial to oocyte survival during vitrification. Resveratrol treatment in ovaries stored for 48 h at 4 °C can reverse the negative effect of oxidative stress in oocytes, with positive effects on embryo development [58]. In fact, resveratrol increased the glutathione (GSH) levels and reduced those of ROS in oocytes; in addition, it ameliorated blastocyst rate formation and cell number in the developed blastocysts [58].
Beneficial effects, such as positive modulation of the apoptotic process and improvement of porcine oocyte resistance, were obtained by Giaretta et al. [59] at the same dosage of resveratrol supplementation used by Lee et al. [52] in different phases of IVM and vitrification/warming procedure. Using the same resveratrol supplementation concentration (2.0 µM), Santos et al. [60] demonstrated a beneficial impact of resveratrol on the developmental competence of vitrified oocytes, only when added to the IVM medium, but not when resveratrol was added as a pre-treatment of the vitrification process.
Since during cryopreservation, functional aberrations in oocytes may intervene due to lipid content variation and formation of ROS, Sprícigo et al. [61] assessed the effect of L-carnitine and/or resveratrol addition to maturation medium before calf oocyte vitrification. L-Carnitine is known both for its modulating activity on lipid metabolism and for its antioxidant action [61]. L-Carnitine and resveratrol supplementation before vitrification decreased spindle damage, while resveratrol addition modulated apoptosis [61]. The addition of L-carnitine or resveratrol before vitrification positively affected the expression of genes of vitrified/warmed oocytes [61].

2.3.3. Embryo Development

Lee et al. [52] examined different resveratrol dose effects on pig embryos obtained by parthenogenesis and/or IVF. The optimal dosage was found at 0.5 µM resveratrol, where (1) a higher percentage of parthenogenetic embryos reached the blastocyst stage at day 7 with a higher total blastocyst cell number; (2) resveratrol incubation negatively affected the expression levels of apoptosis-related genes in parthenogenetic blastocysts [52]. A lower expression of BCL2 and caspase-3 was observed, suggesting a positive effect for porcine embryos [52]. Similar conclusions, but with different dosages, were found by Kwak et al. [62]. The favorable effects were reached at 2.0 µM of resveratrol supplementation during in vitro maturation (IVM), improving the developmental potential of PA and IVF porcine embryos by increasing the intracellular GSH level, decreasing ROS level, and down-regulating apoptosis gene expression during oocyte maturation [62]. In cows, a moderate amount of resveratrol supplemented to the culture medium (0.5 µM) achieved positive effects on the embryo as suggested by the higher development and hatching rates recorded after 48 h post-warming culture [63]. Moreover, in this species, resveratrol supplemented to the in vitro cultured (IVC) medium and/or vitrification solution (VS), at 0.5 µM concentration to protect embryos from the negative effect of cryopreservation, partially restored their quality [64]. In fact, resveratrol addition to IVC medium partially compensated for the gene expression increase for FOXO3 and patatin-like phospholipase domain containing 2 (PNPLA2), but not for BCL2-like 1 and BCL2-associated X, apoptosis regulator (BAX), restoring GSH content in bovine embryos [64].

2.3.4. Aged Oocyte

Maternal aging often impairs the quality of oocytes and embryos and affects, amongst others, mitochondrial function and numbers, and spindle assembly [65,66,67]. These alterations have been related to oxidative stress in human and mouse [65,66,67]. However, similar results have been found in cattle as well. Sugiyama et al. [50] collected oocytes and granulosa cell complexes from early antral follicles of aged cows (>10 age years) and examined the effects of resveratrol on mitochondrial generation, degradation, and quality in oocytes grown in vitro [50]. Interestingly, resveratrol affected both oocytes and granulosa cells, improving the quality of growing oocytes, through up-regulation of mitochondrial biogenesis and degradation of growing oocytes and by modulating genes in granulose cells whose expression levels are associated to the developmental competence of oocytes and embryos [50]. In the following study, it clearly appears that resveratrol ameliorates the quality of oocytes obtained from aged females. The positive effect of resveratrol on mitochondrial function has been proved in experiments performed on oocytes aged in vitro as well. These oocytes are generally obtained using time-dependent deterioration in quality [68] and, thereby, are different from the oocytes obtained from aged females. However, the two different sources of oocytes have similar alterations in the mitochondria, which determine loss of quality. In 2015, Ma et al. [69] reported that SIRT1 expression was notably reduced in pig oocytes that were aged in vitro. Resveratrol treatment during pig oocyte maturation reduced (probably via SIRT1) these defects [69]. In the following study, while SIRT1 impaired mitochondria number and function in the oocytes, the supplementation of IVM medium with resveratrol increased mitochondrial in the developing oocytes, thereby improving their own competence [69]. Overall, all these studies reported that the effect of resveratrol varied in a dose-dependent way and could be species-related. Moreover, here we clarify that resveratrol has favorable effects on mitochondria since it improves their function.

3. Resveratrol Effects on Males

3.1. Impact of Resveratrol on Male Reproductive Function and Spermatogenesis

Estrogens were identified in testes, where they play a paracrine regulatory function [70,71,72], suggesting a possible role for resveratrol, given its structural similarity to estradiol, as previously reported in this review. Several studies reported that resveratrol modulates the estrogen-response system, acting as a regulator of male reproductive function [73]. However, the role of resveratrol in male reproductive function is not clearly established yet, although considerable work has been done. Some studies indicate that resveratrol arguably improves sperm quality in humans [74,75] and domestic animals [76,77,78,79,80]. This seems to be possible thanks to its capacity to pass through the blood–testis barrier, imparting its protective effects in the testis [81]. Resveratrol administration was shown to: (1) decrease germ cell apoptosis [82,83], (2) trigger penile erection [82,83], (3) enhance serum testosterone concentration [82,83], and (4) improve sperm quality and epididymal sperm number [84]. These different actions of resveratrol on the male reproductive system resulted from a direct stimulation of the hypothalamic–pituitary–gonadal axis, with no adverse effects on testes [73]. Resveratrol administration in vivo was used to treat infertility. In men affected by dyszoospermia, resveratrol promoted spermatogenesis by ameliorating the effect induced by 2,5-hexanedione [73]. In this study, it was also established that the expression of c-kit, a specific marker protein of spermatogenic cell membranes, was regulated by resveratrol [73]. Resveratrol has been extensively used during cancer therapy since its positive impact in preserving male reproductive function has been demonstrated. In this scenario, resveratrol administration preserved the metabolic pathways involved in erectile function and provided functional protection of prostatic cancer patients undergoing radiotherapy [85]. Another recent study on the use of resveratrol during cancer therapy determined that the administration of resveratrol during treatment with paclitaxel, diminished DNA fragmentation of rabbit epididymal spermatozoa after cryopreservation [86]. All these results show that resveratrol not only modulates the male reproductive function, but is capable of exerting a direct and protective effect on spermatogenesis. Similar results have been observed in mice affected by cryptorchidism, whereby resveratrol was capable of preserving spermatogenesis after a daily dose treatment [79]. According to this study, the number of primary spermatocytes was higher in the histological section of treated cryptorchid males than in not-treated ones [79]. This effect was also found using resveratrol together with other antioxidant agents. Administration of resveratrol, alpha lipoic acid, and coenzyme Q10 was indeed correlated with a protective effect on radiation-induced spermatogenesis injury [87]. The results of this study demonstrated that resveratrol can act with other antioxidant molecules to enhance sperm maturation [87]. On the contrary, in the same study, no effect on the protection of Leydig cells as a source of testosterone was observed [87].
The positive effects of resveratrol have also been shown in metabolic disorders such as diabetes. Abdeli et al. [88] demonstrated that resveratrol ameliorated Type 1 diabetes mellitus-induced abnormal sperm formation, oxidative stress, and DNA damage and had some effects on PARP signaling pathway in the rat testis [88].
Despite considerable data on the effects of resveratrol, the mechanisms underlying this phenomenon are still unclear. According to several studies, resveratrol directly acts on the expression of sirtuin-1 [43,46,89]. According to Seneret al. [85], resveratrol increased the expression of sirtuin-1, neuronal nitric oxide synthase (nNOS), and endothelial NOS (eNOS) protein expressions of oncological patients treated using resveratrol during radiotherapy [85]. These findings indicate that resveratrol activates sirtuin-1 with subsequent activation of eNOS, leading to enhanced cyclic guanosine monophosphate synthesis via the nitric oxide/cyclic guanosine monophosphate pathway [90]. The activation of this pathway leads to a decreased rate of apoptosis [83] and stimulates germ cell differentiation [82,83,87].
Finally, the positive effect of resveratrol on male reproductive function has led to the study of its analogues that, on the contrary, exerts an inhibitory action on reproductive function. Svechnikow et al. [91] observed an inhibitory effect of resveratrol analogues on steroidogenesis in Leydig cells of rats, indicating novel mechanisms of action. The results of this study may be useful for developing potential therapies as a male contraceptive agent, where suppression of androgen action is needed [91].

3.2. Use of Resveratrol in Sperm Cryopreservation

Cryopreservation of sperm is commonly used for the management and long-term preservation of male fertility in humans and domestic animals [92,93]. However, freeze-thawing processes induce oxidative stress in mammalian spermatozoa because of the production of a large amount of ROS due to high concentration of poly-unsaturated fatty acids located on sperm membranes [81,94,95]. ROS negatively impact sperm quality and motility since they damage cellular proteins, DNA and plasma membrane lipids, with subsequent reduction of capacity of the spermatozoa to fertilize the oocyte [96].
In the ejaculate, the equilibrium of ROS level can be maintained because the seminal plasma contains antioxidant molecules, membrane stabilizers, and sugars [97,98], among others. However, during the procedure of dilution and cooling, the semen is markedly exposed to oxidative stress since spermatozoa do not have adequate reserves of natural antioxidants functioning to reduce the negative impact of ROS, which induces lipid peroxidation (LPO) during the preparation of sperm for cryopreservation [99,100], inducing sperm mitochondrial dysfunction that occurs because of temperature changes, ice formation, and osmotic stress [101]. Furthermore, ROS levels in the sperm significantly increased during the cryopreservation process [102].
The supplementation of antioxidants to the extenders has led to an enhancement in values for the post-thaw sperm quality variables in several species including bull [103], stallion [104], red deer stag [105], dog [106], ram [107], buck goat [108,109], and boar [110,111] semen.
In this scenario, resveratrol has been extensively used as a suitable antioxidant supplement to semen extenders in human, mouse, ram, bull, buffalo, and boar semen [75,86,112,113,114,115,116]. In particular, in vivo and in vitro studies indicated that resveratrol improves sperm quality during the cryopreservation process [74,87], thanks to its protective function against lipid peroxidation (LPO) and DNA damage caused by ROS [75,117].
In humans, resveratrol has been reported to minimize post-thawing DNA damage to spermatozoa [114]. Similarly, in cattle, it has been observed that supplementation of resveratrol in semen extenders improved post-thaw bull sperm quality, in terms of sperm motility, mitochondrial activity, and DNA integrity [114]. The ability of resveratrol to act as an antioxidant was also proved using induced oxidative stress in vitro, where it was reported that mouse [113], cattle [118], buffalo [116] and human spermatozoa [75] can be protected by resveratrol. Furthermore, in frozen-thawed ram sperm, the addition of resveratrol to the tris-egg yolk-glycerol extender was shown to reduce sperm mitochondrial membrane potential [119].There are many other studies that demonstrated how resveratrol may act as an antioxidant. All these studies lead to common conclusions that can be summarized in the ability of resveratrol to: (1) reduce ROS production in the mitochondria; (2) scavenge superoxide radicals, including superoxide anion, hydroxyl radical, and metal-induced radicals; (3) inhibit lipid peroxidation; and (4) regulate the expression of antioxidant cofactors and enzymes [120,121,122]. However, even if there is a clear positive effect on sperm quality, there are no data that indicate that resveratrol may improve motility of freeze-thawed spermatozoa. Moreover, Falchi et al. [123] did not find any antioxidant effect of resveratrol on the post-thawed buck semen [123]. These findings, in agreement with previous studies on buck [124] and other species [125], might indicate that the positive effect of resveratrol on thawed semen could be dependent on dose, sperm variables such as concentration used for freezing, animal species, storage procedure, and entity of stressing conditions. As discussed until now, the use of resveratrol in sperm preservation has been extensively related to its supplementation to extenders before cryopreservation. However, in a recent study, it was shown that resveratrol supplementation in washing and fertilization media improved fertilization capability of bovine sex-sorted spermatozoa with respect to not-treated ones, increasing blastocyst percentage and quality following IVF [126]. This occurred because the spermatozoa had a decreased oxidative stress, since mitochondrial function and acrosomal integrity were ameliorated [126]. The results of this study open the stage for new applications related to the use of resveratrol in the field of artificial reproductive techniques.
Despite the positive effect of resveratrol in protecting spermatozoa from oxidative stress, the mechanisms of action are still an object of debate. In several studies, it was shown that resveratrol activates the AMPK pathway in spermatozoa (Figure 3).
AMPK is a key kinase involved in regulating the cellular redox state by switching the metabolic pathway under stressful conditions [64,65]. It was observed that resveratrol activated AMPK in somatic cells in vitro [127,128,129]. In human spermatozoa, it was demonstrated that AMP-activated protein kinases are mainly present in the whole flagellum and the post-equatorial region of the head [130]. Related to these findings, supplementation of resveratrol increased AMPK activity and was beneficial for protection against cryopreservation-induced oxidative stress of human spermatozoa by improving DNA integrity and transcripts, which were used as markers of sperm quality [130]. Similar results were obtained in boar [131] and goat [132] spermatozoa. In both studies, the addition of resveratrol activated AMPK phosphorylation, allowing the reduction of ROS production, while enhancing the sperm antioxidative defense system such as GSH level and activities of glutathione peroxidase (GPx), SOD, and catalase (Figure 3). However, while it is well-established that resveratrol is capable of activating AMPK, the exact mechanism by which this occurs remains to be clarified [133]. This is because the activation of AMPK can take place through a variety of complex and apparently contradictory mechanisms, which include an increase in the AMP/ATP ratio [130]; inhibition of mitochondrial ATP synthase [134,135]; ROS (independent of the AMP/ATP ratio) [136,137]; as well as upstream serine/threonine kinases, such as LKB1 (Peutz–Jeghers protein) [138,139] and calcium/calmodulin-dependent protein kinase kinase b (CaMKKb) [140,141].

4. Conclusions

Resveratrol is a natural polyphenol with antioxidant, anti-inflammatory, and anti-aging properties. In several studies, it has been shown that resveratrol modulates both female and male reproduction.
In females, resveratrol is considered a phytoestrogen with a chemical structure similar to that of some estrogens. Interestingly, resveratrol is potentially usable alone or in combination with other hormones for its moderate estrogenic effect. Moreover, resveratrol exerts a steroidogenesis modulation in the ovary via sirtuins, especially SIRT1. Finally, resveratrol is a quality enhancer of aged oocytes and a gametes cryo-protectant, with mainly antioxidant and anti-apoptotic effects.
In males, resveratrol modulates the reproductive function by: (1) enhancing the production of testosterone, (2) triggering penile erection, and (3) improving spermatogenesis including sperm differentiation and number in the testes and ejaculate, respectively. The mechanisms of action seem to be exerted by activating the AMPK pathway. Finally, resveratrol is a suitable antioxidant to supplement to semen extenders thanks to its beneficial effect in preserving sperm quality.
However, although considerable research supports the positive impact of resveratrol on human and animal reproduction, further studies are necessary to consolidate the knowledge on the properties of resveratrol and its role in the reproductive functions.

Author Contributions

Writing—original draft preparation, R.P., M.M.; writing—review and editing, R.P., M.M., F.G., M.Z., C.B., T.A.L.B., N.V.; funding acquisition, R.P., M.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by the University of Milan [Piani di Sostegno alla Ricerca 2016–2017, Linea 2].

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Harikumar, K.B.; Aggarwal, B.B. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7, 1020–1035. [Google Scholar] [CrossRef] [Green Version]
  2. Takaoka, M. The Phenolic Substances of White Hellebore (Veratrum Grandiflorum Hoes. Fil). IV. Nippon. Kagaku Kaishi 1940, 61, 96–98. [Google Scholar] [CrossRef]
  3. Nonomura, S.; Kanagawa, H.; Makimoto, A. Chemical Constituents of Polygonaceous Plants. I. Yakugaku Zasshi 1963, 83, 988–990. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Camont, L.; Cottart, C.H.; Rhayem, Y.; Nivet-Antoine, V.; Djelidi, R.; Collin, F.; Beaudeux, J.-L.; Bonnefont-Rousselot, D. Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal. Chim. Acta 2009, 634, 121–128. [Google Scholar] [CrossRef] [PubMed]
  5. Donnez, D.; Jeandet, P.; Clément, C.; Courot, E. Bioproduction of resveratrol and stilbene derivatives by plant cells and microorganisms. Trends Biotechnol. 2009, 27, 706–713. [Google Scholar] [CrossRef]
  6. Hain, R.; Bieseler, B.; Kindl, H.; Schröder, G.; Stöcker, R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 1990, 15, 325–335. [Google Scholar] [CrossRef]
  7. Koushki, M.; Amiri-Dashatan, N.; Ahmadi, N.; Abbaszadeh, H.-A.; Rezaei-Tavirani, M. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci. Nutr. 2018, 6, 2473–2490. [Google Scholar] [CrossRef] [Green Version]
  8. Catalgol, B.; Batirel, S.; Taga, Y.; Ozer, N.K. Resveratrol: French Paradox Revisited. Front. Pharmacol. 2012, 3. [Google Scholar] [CrossRef] [Green Version]
  9. Banez, M.J.; Geluz, M.I.; Chandra, A.; Hamdan, T.; Biswas, O.S.; Bryan, N.S.; Von Schwarz, E.R. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Nutr. Res. 2020, 78, 11–26. [Google Scholar] [CrossRef]
  10. Martinez, J.; Moreno, J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59, 865–870. [Google Scholar] [CrossRef]
  11. Darby, J.R.; Dollah, M.H.M.; Regnault, T.R.; Williams, M.T.; Morrison, J.L. Systematic review: Impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications-Are we ready for the clinic? Pharmacol. Res. 2019, 144, 264–278. [Google Scholar] [CrossRef] [PubMed]
  12. Ochiai, A.; Kuroda, M. Preconception resveratrol intake against infertility: Friend or foe? Reprod. Med. Biol. 2019, 19, 107–113. [Google Scholar] [CrossRef] [PubMed]
  13. Dull, A.-M.; Moga, M.; Oana, D.; Sechel, G.; Burtea, V.; Anastasiu, C.V. Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways. Molecules 2019, 24, 667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Ortega, I.; Duleba, A.J. Ovarian actions of resveratrol. Ann. N. Y. Acad. Sci. 2015, 1348, 86–96. [Google Scholar] [CrossRef] [PubMed]
  15. Svechnikov, K.; Izzo, G.; Landreh, L.; Weisser, J.; Söder, O. Endocrine Disruptors and Leydig Cell Function. J. Biomed. Biotechnol. 2010, 2010, 1–10. [Google Scholar] [CrossRef] [Green Version]
  16. Bowers, J.L.; Tyulmenkov, V.V.; Jernigan, S.C.; Klinge, C.M. Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*. Endocrinology 2000, 141, 3657–3667. [Google Scholar] [CrossRef]
  17. Gehm, B.D.; McAndrews, J.M.; Chien, P.-Y.; Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 14138–14143. [Google Scholar] [CrossRef] [Green Version]
  18. Henry, L.A.; Witt, D.M. Resveratrol: Phytoestrogen Effects on Reproductive Physiology and Behavior in Female Rats. Horm. Behav. 2002, 41, 220–228. [Google Scholar] [CrossRef]
  19. Kris-Etherton, P.M.; Hecker, K.D.; Bonanome, A.; Coval, S.M.; E Binkoski, A.; Hilpert, K.F.; E Griel, A.; Etherton, T.D. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71–88. [Google Scholar] [CrossRef]
  20. Basu, P.; Maier, C. Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives. Biomed. Pharmacother. 2018, 107, 1648–1666. [Google Scholar] [CrossRef]
  21. Milner, J.A.; McDonald, S.S.; Anderson, D.E.; Greenwald, P. Reviews. Nutr. Cancer 2001, 41, 1–16. [Google Scholar] [CrossRef] [PubMed]
  22. Ko, J.-H.; Sethi, G.; Um, J.-Y.; Shanmugam, M.K.; Arfuso, F.; Kumar, A.P.; Bishayee, A.; Ahn, K.S. The Role of Resveratrol in Cancer Therapy. Int. J. Mol. Sci. 2017, 18, 2589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Levenson, V.V.; Gehm, B.D.; Pearce, S.T.; Horiguchi, J.; Simons, L.A.; Ward, J.E.; Jameson, J.L.; Jordan, V.C. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER? Int. J. Cancer 2003, 104, 587–596. [Google Scholar] [CrossRef] [PubMed]
  24. Louis, X.L.; Raj, P.; Chan, L.; Zieroth, S.; Netticadan, T.; Wigle, J.T. Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent? Can. J. Physiol. Pharmacol. 2019, 97, 503–514. [Google Scholar] [CrossRef] [Green Version]
  25. Goswami, S.K.; Das, D.K. Resveratrol and chemoprevention. Cancer Lett. 2009, 284, 1–6. [Google Scholar] [CrossRef]
  26. Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises. J. Nutr. Biochem. 2005, 16, 449–466. [Google Scholar] [CrossRef]
  27. Baker, M.E.; Lathe, R. The promiscuous estrogen receptor: Evolution of physiological estrogens and response to phytochemicals and endocrine disruptors. J. Steroid Biochem. Mol. Biol. 2018, 184, 29–37. [Google Scholar] [CrossRef] [Green Version]
  28. Stahl, S.; Chun, T.-Y.; Gray, W.G. Phytoestrogens Act as Estrogen Agonists in an Estrogen-Responsive Pituitary Cell Line. Toxicol. Appl. Pharmacol. 1998, 152, 41–48. [Google Scholar] [CrossRef]
  29. Kuiper, G.G.J.M.; Carlsson, B.; Grandien, K.; Enmark, E.; Häggblad, J.; Nilsson, S.; Gustafsson, J.-A. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology 1997, 138, 863–870. [Google Scholar] [CrossRef]
  30. Lee, S.-H.; Lee, J.-H.; Lee, H.-Y.; Min, A.K.-J. Sirtuin signaling in cellular senescence and aging. BMB Rep. 2019, 52, 24–34. [Google Scholar] [CrossRef] [Green Version]
  31. Ong, A.L.; Ramasamy, T.S. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res. Rev. 2018, 43, 64–80. [Google Scholar] [CrossRef] [PubMed]
  32. Shin, J.; Kim, J.; Park, H.; Kim, J. Investigating the role of Sirtuins in cell reprogramming. BMB Rep. 2018, 51, 500–507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Lagunas-Rangel, F.A. Current role of mammalian sirtuins in DNA repair. DNA Repair 2019, 80, 85–92. [Google Scholar] [CrossRef] [PubMed]
  34. Zhao, E.; Hou, J.; Ke, X.; Abbas, M.N.; Kausar, S.; Zhang, L.; Cui, H. The Roles of Sirtuin Family Proteins in Cancer Progression. Cancers 2019, 11, 1949. [Google Scholar] [CrossRef] [Green Version]
  35. Di Emidio, G.; Falone, S.; Vitti, M.; D’Alessandro, A.M.; Vento, M.; Di Pietro, C.; Amicarelli, F.; Tatone, C. SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging. Hum. Reprod. 2014, 29, 2006–2017. [Google Scholar] [CrossRef]
  36. Zhao, L.; Cao, J.; Hu, K.; He, X.; Yun, D.; Tong, T.; Han, L. Sirtuins and their Biological Relevance in Aging and Age-Related Diseases. Aging Dis. 2020, 11, 927–945. [Google Scholar] [CrossRef]
  37. Singh, C.K.; Chhabra, G.; Ndiaye, M.A.; Garcia-Peterson, L.M.; Mack, N.J.; Ahmad, N. The Role of Sirtuins in Antioxidant and Redox Signaling. Antioxid. Redox Signal. 2018, 28, 643–661. [Google Scholar] [CrossRef]
  38. Ye, X.; Li, M.; Hou, T.; Gao, T.; Zhu, W.-G.; Yang, Y. Sirtuins in glucose and lipid metabolism. Oncotarget 2016, 8, 1845–1859. [Google Scholar] [CrossRef] [Green Version]
  39. Tatone, C.; Di Emidio, G.; Vitti, M.; Di Carlo, M.; Santini, S.J.; D’Alessandro, A.M.; Falone, S.; Amicarelli, F. Sirtuin Functions in Female Fertility: Possible Role in Oxidative Stress and Aging. Oxidative Med. Cell. Longev. 2015, 2015, 1–11. [Google Scholar] [CrossRef] [Green Version]
  40. Józkowiak, M.; Hutchings, G.; Jankowski, M.; Kulcenty, K.; Mozdziak, P.; Kempisty, B.; Spaczyński, R.Z.; Piotrowska-Kempisty, H. The Stemness of Human Ovarian Granulosa Cells and the Role of Resveratrol in the Differentiation of MSCs—A Review Based on Cellular and Molecular Knowledge. Cells 2020, 9, 1418. [Google Scholar] [CrossRef]
  41. Rato, L.; Alves, M.; Silva, B.M.; Sousa, M.; Oliveira, P.F. Sirtuins: Novel Players in Male Reproductive Health. Curr. Med. Chem. 2016, 23, 1084–1099. [Google Scholar] [CrossRef] [PubMed]
  42. Sirotkin, A. The Role and Application of Sirtuins and mTOR Signaling in the Control of Ovarian Functions. Cells 2016, 5, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Michan, S.; Sinclair, D. Sirtuins in mammals: Insights into their biological function. Biochem. J. 2007, 404, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Finkel, T.; Deng, C.-X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nat. Cell Biol. 2009, 460, 587–591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Xiang, Y.; Xu, J.; Li, L.; Lin, X.; Chen, X.; Zhang, X.; Fu, Y.; Luo, L. Calorie restriction increases primordial follicle reserve in mature female chemotherapy-treated rats. Gene 2012, 493, 77–82. [Google Scholar] [CrossRef]
  46. Morita, Y.; Wada-Hiraike, O.; Yano, T.; Shirane, A.; Hirano, M.; Hiraike, H.; Koyama, S.; Oishi, H.; Yoshino, O.; Miyamoto, Y.; et al. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: An implicative role of SIRT1 in the ovary. Reprod. Biol. Endocrinol. 2012, 10, 14. [Google Scholar] [CrossRef] [Green Version]
  47. Zhao, F.; Zhao, W.; Ren, S.; Fu, Y.; Fang, X.; Wang, X.; Li, B. Roles of SIRT1 in granulosa cell apoptosis during the process of follicular atresia in porcine ovary. Anim. Reprod. Sci. 2014, 151, 34–41. [Google Scholar] [CrossRef]
  48. Khan, I.; Kim, S.W.; Lee, K.-L.; Song, S.-H.; Mesalam, A.; Chowdhury, M.M.R.; Uddin, Z.; Park, K.H.; Kong, I.-K. Polydatin improves the developmental competence of bovine embryos in vitro via induction of sirtuin 1 (Sirt1). Reprod. Fertil. Dev. 2017, 29, 2011. [Google Scholar] [CrossRef]
  49. Wang, F.; Tian, X.; Zhang, L.; He, C.; Ji, P.; Li, Y.; Tan, D.; Liu, G. Beneficial effect of resveratrol on bovine oocyte maturation and subsequent embryonic development after in vitro fertilization. Fertil. Steril. 2014, 101, 577–586.e1. [Google Scholar] [CrossRef]
  50. Sugiyama, M.; Kawahara-Miki, R.; Kawana, H.; Shirasuna, K.; Kuwayama, T.; Iwata, H. Resveratrol-induced mitochondrial synthesis and autophagy in oocytes derived from early antral follicles of aged cows. J. Reprod. Dev. 2015, 61, 251–259. [Google Scholar] [CrossRef] [Green Version]
  51. Comizzoli, P.; Wildt, D.; Pukazhenthi, B. In VitroCompaction of Germinal Vesicle Chromatin is Beneficial to Survival of Vitrified Cat Oocytes. Reprod. Domest. Anim. 2009, 44, 269–274. [Google Scholar] [CrossRef] [PubMed]
  52. Lee, K.; Wang, C.; Chaille, J.M.; Machaty, Z. Effect of resveratrol on the development of porcine embryos produced in vitro. J. Reprod. Dev. 2010, 56, 330–335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Paredes, S.D.; Korkmaz, A.; Manchester, L.C.; Tan, D.-X.; Reiter, R.J. Phytomelatonin: A review. J. Exp. Bot. 2008, 60, 57–69. [Google Scholar] [CrossRef] [PubMed]
  54. Lee, S.; Jin, J.-X.; Taweechaipaisankul, A.; Kim, G.A.; Lee, B.-C. Synergistic effects of resveratrol and melatonin on in vitro maturation of porcine oocytes and subsequent embryo development. Theriogenology 2018, 114, 191–198. [Google Scholar] [CrossRef] [PubMed]
  55. Sovernigo, T.; Adona, P.R.; Monzani, P.; Guemra, S.; Barros, F.; Lopes, F.; Leal, C. Effects of supplementation of medium with different antioxidants during in vitro maturation of bovine oocytes on subsequent embryo production. Reprod. Domest. Anim. 2017, 52, 561–569. [Google Scholar] [CrossRef]
  56. Takeo, S.; Sato, D.; Kimura, K.; Monji, Y.; Kuwayama, T.; Kawahara-Miki, R.; Iwata, H. Resveratrol Improves the Mitochondrial Function and Fertilization Outcome of Bovine Oocytes. J. Reprod. Dev. 2014, 60, 92–99. [Google Scholar] [CrossRef] [Green Version]
  57. Fernandes, G.D.S.; Silva, G.D.B.; Pavan, A.R.; Chiba, D.E.; Chung, M.C.; Dos Santos, J.L. Epigenetic Regulatory Mechanisms Induced by Resveratrol. Nutrients 2017, 9, 1201. [Google Scholar] [CrossRef] [Green Version]
  58. Piras, A.R.; Ariu, F.; Falchi, L.; Zedda, M.T.; Pau, S.; Schianchi, E.; Paramio, M.; Bogliolo, L. Resveratrol treatment during maturation enhances developmental competence of oocytes after prolonged ovary storage at 4 °C in the domestic cat model. Theriogenology 2020, 144, 152–157. [Google Scholar] [CrossRef]
  59. Giaretta, E.; Spinaci, M.; Bucci, D.; Tamanini, C.; Galeati, G. Effects of Resveratrol on Vitrified Porcine Oocytes. Oxidative Med. Cell. Longev. 2013, 2013, 1–7. [Google Scholar] [CrossRef]
  60. Santos, E.; Appeltant, R.; Dang-Nguyen, T.; Noguchi, J.; Kaneko, H.; Kikuchi, K.; Somfai, T. The effect of resveratrol on the developmental competence of porcine oocytes vitrified at germinal vesicle stage. Reprod. Domest. Anim. 2017, 53, 304–312. [Google Scholar] [CrossRef]
  61. Sprícigo, J.F.; Morató, R.; Arcarons, N.; Yeste, M.; Dode, M.A.; López-Bejar, M.; Mogas, T. Assessment of the effect of adding L-carnitine and/or resveratrol to maturation medium before vitrification on in vitro -matured calf oocytes. Theriogenology 2017, 89, 47–57. [Google Scholar] [CrossRef] [PubMed]
  62. Kwak, S.-S.; Cheong, S.-A.; Jeon, Y.; Lee, E.; Choi, K.-C.; Jeung, E.-B.; Hyun, S.-H. The effects of resveratrol on porcine oocyte in vitro maturation and subsequent embryonic development after parthenogenetic activation and in vitro fertilization. Theriogenology 2012, 78, 86–101. [Google Scholar] [CrossRef] [PubMed]
  63. Salzano, A.; Albero, G.; Zullo, G.; Neglia, G.; Abdel-Wahab, A.; Bifulco, G.; Zicarelli, L.; Gasparrini, B. Effect of resveratrol supplementation during culture on the quality and cryotolerance of bovine in vitro produced embryos. Anim. Reprod. Sci. 2014, 151, 91–96. [Google Scholar] [CrossRef] [PubMed]
  64. Gaviria, S.M.; Herrera, A.L.; Urrego, R.; Betancur, G.R.; Zuluaga, J.J.E. Effect of resveratrol on vitrified in vitro produced bovine embryos: Recovering the initial quality. Cryobiology 2019, 89, 42–50. [Google Scholar] [CrossRef]
  65. Pasquariello, R.; Ermisch, A.F.; Silva, E.; McCormick, S.; Logsdon, D.; Barfield, J.P.; Schoolcraft, W.B.; Krisher, R.L. Alterations in oocyte mitochondrial number and function are related to spindle defects and occur with maternal aging in mice and humans†. Biol. Reprod. 2018, 100, 971–981. [Google Scholar] [CrossRef]
  66. Silva, E.; Greene, A.F.; Strauss, K.; Herrick, J.R.; Schoolcraft, W.B.; Krisher, R.L. Antioxidant supplementation during in vitro culture improves mitochondrial function and development of embryos from aged female mice. Reprod. Fertil. Dev. 2015, 27, 975–983. [Google Scholar] [CrossRef]
  67. Krisher, R.L. Maternal age affects oocyte developmental potential at both ends of the age spectrum. Reprod. Fertil. Dev. 2018, 31, 1–9. [Google Scholar] [CrossRef]
  68. Miao, Y.-L.; Kikuchi, K.; Sun, Q.-Y.; Schatten, H. Oocyte aging: Cellular and molecular changes, developmental potential and reversal possibility. Hum. Reprod. Updat. 2009, 15, 573–585. [Google Scholar] [CrossRef] [Green Version]
  69. Ma, R.; Zhang, Y.; Zhang, L.; Han, J.; Rui, R. Sirt1 protects pig oocyte against in vitro aging. Anim. Sci. J. 2015, 86, 826–832. [Google Scholar] [CrossRef]
  70. Sharpe, R.M. Do males rely on female hormones? Nat. Cell Biol. 1997, 390, 447–448. [Google Scholar] [CrossRef]
  71. Bunney, P.; Zink, A.; Holm, A.; Billington, C.; Kotz, C. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol. Behav. 2017, 176, 139–148. [Google Scholar] [CrossRef] [PubMed]
  72. Sharpe, R.M. The Roles of Oestrogen in the Male. Trends Endocrinol. Metab. 1998, 9, 371–377. [Google Scholar] [CrossRef]
  73. Juan, M.E.; González-Pons, E.; Munuera, T.; Ballester, J.; Rodríguez-Gil, J.E.; Planas, J.M. trans-Resveratrol, a Natural Antioxidant from Grapes, Increases Sperm Output in Healthy Rats. J. Nutr. 2005, 135, 757–760. [Google Scholar] [CrossRef] [PubMed]
  74. Garcez, M.E.; Branco, C.D.S.; Lara, L.V.; Pasqualotto, F.F.; Salvador, M. Effects of resveratrol supplementation on cryopreservation medium of human semen. Fertil. Steril. 2010, 94, 2118–2121. [Google Scholar] [CrossRef] [PubMed]
  75. Collodel, G.; Federico, M.; Geminiani, M.; Martini, S.; Bonechi, C.; Rossi, C.; Figura, N.; Moretti, E. Effect of trans-resveratrol on induced oxidative stress in human sperm and in rat germinal cells. Reprod. Toxicol. 2011, 31, 239–246. [Google Scholar] [CrossRef] [PubMed]
  76. Ourique, G.M.; Finamor, I.A.; Saccol, E.M.; Riffel, A.P.; Pês, T.S.; Gutierrez, K.; Gonçalves, P.B.; Baldisserotto, B.; Pavanato, M.A.; Barreto, K.P. Resveratrol improves sperm motility, prevents lipid peroxidation and enhances antioxidant defences in the testes of hyperthyroid rats. Reprod. Toxicol. 2013, 37, 31–39. [Google Scholar] [CrossRef]
  77. Chirumbolo, S. Resveratrol in spermatogenesis. Cell Biol. Int. 2015, 39, 775–776. [Google Scholar] [CrossRef]
  78. Faid, I.; Al-Hussaini, H.; Kilarkaje, N. Resveratrol alleviates diabetes-induced testicular dysfunction by inhibiting oxidative stress and c-Jun N-terminal kinase signaling in rats. Toxicol. Appl. Pharmacol. 2015, 289, 482–494. [Google Scholar] [CrossRef]
  79. Li, E.-Z.; Guo, Y.; Wang, G.; Chen, F.; Li, Q. Effect of resveratrol on restoring spermatogenesis in experimental cryptorchid mice and analysis of related differentially expressed proteins. Cell Biol. Int. 2015, 39, 733–740. [Google Scholar] [CrossRef]
  80. Banerjee, B.; Nandi, P.; Chakraborty, S.; Raha, S.; Sen, P.C.; Jana, K. Resveratrol ameliorates benzo(a)pyrene-induced testicular dysfunction and apoptosis: Involvement of p38 MAPK/ATF2/iNOS signaling. J. Nutr. Biochem. 2016, 34, 17–29. [Google Scholar] [CrossRef]
  81. Aitken, R.J.; Roman, S.D. Antioxidant Systems and Oxidative Stress in the Testes. Oxidative Med. Cell. Longev. 2008, 1, 15–24. [Google Scholar] [CrossRef] [Green Version]
  82. Revel, A.; Raanani, H.; Younglai, E.; Xu, J.; Rogers, I.; Han, R.N.; Savouret, J.-F.; Casper, R.F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 2003, 23, 255–261. [Google Scholar] [CrossRef] [PubMed]
  83. Uguralp, S.; Usta, U.; Mizrak, B. Resveratrol May Reduce Apoptosis of Rat Testicular Germ Cells After Experimental Testicular Torsion. Eur. J. Pediatr. Surg. 2005, 15, 333–336. [Google Scholar] [CrossRef] [PubMed]
  84. Shin, S.; Jeon, J.H.; Park, N.; Jang, M.-J.; Choi, J.H.; Choi, B.-H.; Joo, S.S.; Nahm, S.-S.; Kim, J.-C.; Kim, Y.-B. trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Arch. Pharmacal Res. 2008, 31, 83–87. [Google Scholar] [CrossRef]
  85. Sener, G.; Tavukcu, H.H.; Atasoy, B.M.; Cevik, O.; Çilingir Özlem, T.; Cetinel, S.; Degerli, A.D.; Tinay, I.; Şimşĕk, F.; Akbal, C.; et al. Resveratrol treatment may preserve the erectile function after radiotherapy by restoring antioxidant defence mechanisms, SIRT1 and NOS protein expressions. Int. J. Impot. Res. 2018, 30, 179–188. [Google Scholar] [CrossRef]
  86. Ili, P.; Sari, F.; Bucak, M.N.; Öztürk, C.; Güngör, Ş.; Ataman, M.B. DNA damaging effect of paclitaxel in the epididymal sperms as a chemotherapeutic agent and possible remedies to prevent this effect: A study on reproductive potential of male cancer patients of reproductive age. Theriogenology 2019, 132, 201–211. [Google Scholar] [CrossRef]
  87. Najafi, M.; Cheki, M.; Amini, P.; Javadi, A.; Shabeeb, D.; Musa, A.E. Evaluating the protective effect of resveratrol, Q10, and alpha-lipoic acid on radiation-induced mice spermatogenesis injury: A histopathological study. Int. J. Reprod. Biomed. 2019, 17, 907–914. [Google Scholar] [CrossRef] [PubMed]
  88. Abdelali, A.; Al Bader, M.; Kilarkaje, N. Effects of Trans-Resveratrol on hyperglycemia-induced abnormal spermatogenesis, DNA damage and alterations in poly (ADP-ribose) polymerase signaling in rat testis. Toxicol. Appl. Pharmacol. 2016, 311, 61–73. [Google Scholar] [CrossRef] [PubMed]
  89. Repossi, G.; Das, U.N.; Eynard, A.R. Molecular Basis of the Beneficial Actions of Resveratrol. Arch. Med. Res. 2020, 51, 105–114. [Google Scholar] [CrossRef]
  90. Fukuhara, S.; Tsujimura, A.; Okuda, H.; Yamamoto, K.; Takao, T.; Miyagawa, Y.; Nonomura, N.; Okuyama, A. Vardenafil and Resveratrol Synergistically Enhance the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in Corpus Cavernosal Smooth Muscle Cells and Its Therapeutic Potential for Erectile Dysfunction in the Streptozotocin-Induced Diabetic Rat: Preliminary Findings. J. Sex. Med. 2011, 8, 1061–1071. [Google Scholar] [CrossRef] [PubMed]
  91. Svechnikov, K.; Spatafora, C.; Svechnikova, I.; Tringali, C.; Söder, O. Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cellsin vitro. J. Appl. Toxicol. 2009, 29, 673–680. [Google Scholar] [CrossRef] [PubMed]
  92. Sharma, V. Sperm storage for cancer patients in the UK: A review of current practice. Hum. Reprod. 2011, 26, 2935–2943. [Google Scholar] [CrossRef] [PubMed]
  93. Hezavehei, M.; Sharafi, M.; Kouchesfahani, H.M.; Henkel, R.; Agarwal, A.; Esmaeili, V.; Shahverdi, A.H. Sperm cryopreservation: A review on current molecular cryobiology and advanced approaches. Reprod. Biomed. Online 2018, 37, 327–339. [Google Scholar] [CrossRef] [PubMed]
  94. Alvarez, J.G.; Storey, B.T. Role of glutathione peroxidase in protecting mammalian spermatozoa from loss of motility caused by spontaneous lipid peroxidation. Gamete Res. 1989, 23, 77–90. [Google Scholar] [CrossRef] [PubMed]
  95. Bell, M.; Wang, R.; Hellstrom, W.J.; Sikka, S.C. Effect of cryoprotective additives and cryopreservation protocol on sperm membrane lipid peroxidation and recovery of motile human sperm. J. Androl. 1993, 14, 472–478. [Google Scholar] [PubMed]
  96. Bansal, A.K.; Bilaspuri, G.S. Impacts of Oxidative Stress and Antioxidants on Semen Functions. Vet.-Med. Int. 2011, 2011, 1–7. [Google Scholar] [CrossRef] [Green Version]
  97. Maxwell, W.; Johnson, L. Physiology of spermatozoa at high dilution rates: The influence of seminal plasma. Theriogenology 1999, 52, 1353–1362. [Google Scholar] [CrossRef]
  98. Chen, H.; Cheung, M.P.L.; Chow, P.H.; Cheung, A.L.M.; Liu, W.; O, W.S. Protection of sperm DNA against oxidative stress in vivo by accessory sex gland secretions in male hamsters. Reproduction 2002, 124, 491–499. [Google Scholar] [CrossRef]
  99. Aurich, J.; Schönherr, U.; Hoppe, H.; Aurich, C. Effects of antioxidants on motility and membrane integrity of chilled-stored stallion semen. Theriogenology 1997, 48, 185–192. [Google Scholar] [CrossRef]
  100. Storey, B.T. Biochemistry of the induction and prevention of lipoperoxidative damage in human spermatozoa. Mol. Hum. Reprod. 1997, 3, 203–213. [Google Scholar] [CrossRef]
  101. Di Santo, M.; Tarozzi, N.; Nadalini, M.; Borini, A. Human Sperm Cryopreservation: Update on Techniques, Effect on DNA Integrity, and Implications for ART. Adv. Urol. 2011, 2012, 1–12. [Google Scholar] [CrossRef] [PubMed]
  102. Bathgate, R. Antioxidant Mechanisms and their Benefit on Post-thaw Boar Sperm Quality. Reprod. Domest. Anim. 2011, 46, 23–25. [Google Scholar] [CrossRef] [PubMed]
  103. Sarıözkan, S.; Bucak, M.N.; Tuncer, P.B.; Ulutaş, P.A.; Bilgen, A. The influence of cysteine and taurine on microscopic–oxidative stress parameters and fertilizing ability of bull semen following cryopreservation. Cryobiology 2009, 58, 134–138. [Google Scholar] [CrossRef] [PubMed]
  104. Nouri, H.; Shojaeian, K.; Samadian, F.; Lee, S.; Kohram, H.; Lee, J. Using Resveratrol and Epigallocatechin-3-Gallate to Improve Cryopreservation of Stallion Spermatozoa With Low Quality. J. Equine Vet.-Sci. 2018, 70, 18–25. [Google Scholar] [CrossRef]
  105. Sánchez-Rubio, F.; Fernández-Santos, M.; Castro-Vázquez, L.; García-Álvarez, O.; Maroto-Morales, A.; Soler, A.; Martinez-Pastor, F.; Garde, J.J. Cinnamtannin B-1, a novel antioxidant for sperm in red deer. Anim. Reprod. Sci. 2018, 195, 44–52. [Google Scholar] [CrossRef]
  106. Andersen, A.H.; Thinnesen, M.; Failing, K.; Pesch, S. Effect of reduced glutathione (GSH) supplementation to Tris-egg yolk extender on chilled semen variables of dogs. Anim. Reprod. Sci. 2018, 198, 145–153. [Google Scholar] [CrossRef]
  107. Aisen, E.; Medina, V.; Venturino, A. Cryopreservation and post-thawed fertility of ram semen frozen in different trehalose concentrations. Theriogenology 2002, 57, 1801–1808. [Google Scholar] [CrossRef]
  108. Atessahin, A.; Bucak, M.N.; Tuncer, P.B.; Kızıl, M. Effects of anti-oxidant additives on microscopic and oxidative parameters of Angora goat semen following the freeze–thawing process. Small Rumin. Res. 2008, 77, 38–44. [Google Scholar] [CrossRef]
  109. Reddy, V.S.; Yadav, B.; Yadav, C.L.; Anand, M.; Swain, D.K.; Kumar, D.; Kritania, D.; Madan, A.K.; Kumar, J.; Yadav, S. Effect of sericin supplementation on heat shock protein 70 (HSP70) expression, redox status and post thaw semen quality in goat. Cryobiology 2018, 84, 33–39. [Google Scholar] [CrossRef]
  110. Gadea, J.; Sellés, E.; Marco, M.A.; Coy, P.; Parra, C.M.; Romar, R.; Ruiz, S. Decrease in glutathione content in boar sperm after cryopreservation. Theriogenology 2004, 62, 690–701. [Google Scholar] [CrossRef]
  111. Estrada, E.; Rodríguez-Gil, J.E.; Rocha, L.G.; Balasch, S.; Bonet, S.; Yeste, M. Supplementing cryopreservation media with reduced glutathione increases fertility and prolificacy of sows inseminated with frozen-thawed boar semen. Andrology 2013, 2, 88–99. [Google Scholar] [CrossRef] [PubMed]
  112. Sarlós, P.; Molnár, A.; Kokai, M. Comparative evaluation of the effect of antioxidants in the conservation of ram semen. Acta Vet.-Hung. 2002, 50, 235–245. [Google Scholar] [CrossRef] [Green Version]
  113. Mojica-Villegas, M.A.; Izquierdo-Vega, J.; Chamorro-Cevallos, G.; Sánchez-Gutiérrez, M. Protective Effect of Resveratrol on Biomarkers of Oxidative Stress Induced by Iron/Ascorbate in Mouse Spermatozoa. Nutrients 2014, 6, 489–503. [Google Scholar] [CrossRef]
  114. Bucak, M.N.; Ataman, M.B.; Başpınar, N.; Uysal, O.; Taşpınar, M.; Bilgili, A.; Öztürk, C.; Güngör, Ş.; Inanç, M.E.; Akal, E. Lycopene and resveratrol improve post-thaw bull sperm parameters: Sperm motility, mitochondrial activity and DNA integrity. Andrology 2014, 47, 545–552. [Google Scholar] [CrossRef] [PubMed]
  115. Bucci, D.; Spinaci, M.; Yeste, M.; Mislei, B.; Gadani, B.; Martinez, N.P.; Love, C.; Mari, G.; Tamanini, C.; Galeati, G. Combined effects of resveratrol and epigallocatechin-3-gallate on post thaw boar sperm and IVF parameters. Theriogenology 2018, 117, 16–25. [Google Scholar] [CrossRef] [PubMed]
  116. Ahmed, H.; Jahan, S.; Ullah, H.; Ullah, F.; Salman, M.M. The addition of resveratrol in tris citric acid extender ameliorates post-thaw quality parameters, antioxidant enzymes levels, and fertilizing capability of buffalo (Bubalus bubalis) bull spermatozoa. Theriogenology 2020, 152, 106–113. [Google Scholar] [CrossRef] [PubMed]
  117. Branco, C.D.S.; Garcez, M.E.; Pasqualotto, F.F.; Erdtman, B.; Salvador, M. Resveratrol and ascorbic acid prevent DNA damage induced by cryopreservation in human semen. Cryobiology 2010, 60, 235–237. [Google Scholar] [CrossRef]
  118. Tvrda, E.; Kovacikova, E.; Tušimová, E.; Massányi, P.; Lukáč, N. Resveratrol offers protection to oxidative stress induced by ferrous ascorbate in bovine spermatozoa. J. Environ. Sci. Health Part A 2015, 50, 1440–1451. [Google Scholar] [CrossRef]
  119. Silva, E.; Cajueiro, J.; Silva, S.; Soares, P.; Guerra, M. Effect of antioxidants resveratrol and quercetin on in vitro evaluation of frozen ram sperm. Theriogenology 2012, 77, 1722–1726. [Google Scholar] [CrossRef]
  120. Pervaiz, S.; Holme, A.L. Resveratrol: Its Biologic Targets and Functional Activity. Antiox. Redox Signal. 2009, 11, 2851–2897. [Google Scholar] [CrossRef]
  121. Leonard, S.S.; Xia, C.; Jiang, B.-H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309, 1017–1026. [Google Scholar] [CrossRef] [PubMed]
  122. Willcox, J.K.; Ash, S.L.; Catignani, G.L. Antioxidants and Prevention of Chronic Disease. Crit. Rev. Food Sci. Nutr. 2004, 44, 275–295. [Google Scholar] [CrossRef] [PubMed]
  123. Falchi, L.; Pau, S.; Pivato, I.; Bogliolo, L.; Zedda, M.-T. Resveratrol supplementation and cryopreservation of buck semen. Cryobiology 2020, 95, 60–67. [Google Scholar] [CrossRef] [PubMed]
  124. Silva, E.; Arruda, L.; Silva, S.; Souza, H.; Guerra, M. High resveratrol or quercetin concentrations reduce the oscillation index of frozen goat semen. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2016, 68, 1237–1243. [Google Scholar] [CrossRef] [Green Version]
  125. Longobardi, V.; Zullo, G.; Salzano, A.; De Canditiis, C.; Cammarano, A.; De Luise, L.; Puzio, M.V.; Neglia, G.; Gasparrini, B. Resveratrol prevents capacitation-like changes and improves in vitro fertilizing capability of buffalo frozen-thawed sperm. Theriogenology 2017, 88, 1–8. [Google Scholar] [CrossRef]
  126. Li, C.-Y.; Zhao, Y.-H.; Hao, H.-S.; Wang, H.-Y.; Huang, J.-M.; Yan, C.-L.; Du, W.-H.; Pang, Y.-W.; Zhang, P.-P.; Liu, Y.; et al. Resveratrol significantly improves the fertilisation capacity of bovine sex-sorted semen by inhibiting apoptosis and lipid peroxidation. Sci. Rep. 2018, 8, 7603. [Google Scholar] [CrossRef] [Green Version]
  127. Zhao, Y.; Hu, X.; Liu, Y.; Dong, S.; Wen, Z.; He, W.; Zhang, S.; Huang, Q.; Shi, M. ROS signaling under metabolic stress: Cross-talk between AMPK and AKT pathway. Mol. Cancer 2017, 16, 79. [Google Scholar] [CrossRef] [Green Version]
  128. Price, N.L.; Gomes, A.P.; Ling, A.J.; Duarte, F.V.; Martin-Montalvo, A.; North, B.J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J.S.; et al. SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function. Cell Metab. 2012, 15, 675–690. [Google Scholar] [CrossRef] [Green Version]
  129. Hawley, S.A.; Ross, F.A.; Chevtzoff, C.; Green, K.A.; Evans, A.; Fogarty, S.; Towler, M.C.; Brown, L.J.; Ogunbayo, O.A.; Hardie, D.G.; et al. Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation. Cell Metab. 2010, 11, 554–565. [Google Scholar] [CrossRef] [Green Version]
  130. Nashtaei, M.S.; Amidi, F.; Gilani, M.A.S.; Aleyasin, A.; Bakhshalizadeh, S.; Naji, M.; Nekoonam, S. Protective features of resveratrol on human spermatozoa cryopreservation may be mediated through 5’ AMP-activated protein kinase activation. Andrology 2016, 5, 313–326. [Google Scholar] [CrossRef]
  131. Zhu, Z.; Li, R.; Fan, X.; Lv, Y.; Zheng, Y.; Hoque, S.A.M.; Wu, D.; Zeng, W. Resveratrol Improves Boar Sperm Quality via 5’AMP-Activated Protein Kinase Activation during Cryopreservation. Oxidative Med. Cell. Longev. 2019, 2019, 5921503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Zhu, Z.; Li, R.; Ma, G.; Bai, W.; Fan, X.; Lv, Y.; Luo, J.; Zeng, W. 5’-AMP-Activated Protein Kinase Regulates Goat Sperm Functions via Energy Metabolism In Vitro. Cell. Physiol. Biochem. 2018, 47, 2420–2431. [Google Scholar] [CrossRef] [PubMed]
  133. Yun, H.; Park, S.; Kim, M.-J.; Yang, W.K.; Im, D.U.; Yang, K.R.; Hong, J.; Choe, W.; Kang, I.; Kim, S.S.; et al. AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J. 2014, 281, 4421–4438. [Google Scholar] [CrossRef] [PubMed]
  134. Zheng, J.; Ramirez, V.D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 2000, 130, 1115–1123. [Google Scholar] [CrossRef]
  135. Gledhill, J.R.; Montgomery, M.G.; Leslie, A.G.W.; Walker, J.E. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc. Natl. Acad. Sci. USA 2007, 104, 13632–13637. [Google Scholar] [CrossRef] [Green Version]
  136. Zhang, M.; Dong, Y.; Xu, J.; Xie, Z.; Wu, Y.; Song, P.; Guzman, M.; Wu, J.; Zou, M.-H. Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ. Res. 2007, 102, 328–337. [Google Scholar] [CrossRef]
  137. Emerling, B.M.; Weinberg, F.; Snyder, C.; Burgess, Z.; Mutlu, G.M.; Viollet, B.; Budinger, G.S.; Chandel, N.S. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic. Biol. Med. 2009, 46, 1386–1391. [Google Scholar] [CrossRef] [Green Version]
  138. Dasgupta, B.; Milbrandt, J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA 2007, 104, 7217–7222. [Google Scholar] [CrossRef] [Green Version]
  139. Biasutto, L.; Mattarei, A.; Zoratti, M. Resveratrol and Health: The Starting Point. ChemBioChem 2012, 13, 1256–1259. [Google Scholar] [CrossRef]
  140. Vingtdeux, V.; Giliberto, L.; Zhao, H.; Chandakkar, P.; Wu, Q.; Simon, J.E.; Janle, E.M.; Lobo, J.; Ferruzzi, M.G.; Davies, P.; et al. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism. J. Biol. Chem. 2010, 285, 9100–9113. [Google Scholar] [CrossRef] [Green Version]
  141. Park, S.-J.; Khan, F.A.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A.L.; et al. Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases. Cell 2012, 148, 421–433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Molecules 25 04554 g001 550
Figure 1. Chemical structures of (A) trans- and (B) cis- resveratrol.
Figure 1. Chemical structures of (A) trans- and (B) cis- resveratrol.
Molecules 25 04554 g001
Molecules 25 04554 g002 550
Figure 2. Mechanisms of action of resveratrol on silent information regulator 2 type 1 (SIRT1). Following a stressful event, resveratrol activates SIRT1 that binds different genes such as NF-kB, FOXO4, HIF 2 alpha, FOXO1, FOXO3, NBS1, and PGC-1 alpha. The activation of these genes is correlated with regulation of energy homeostasis, cell survival, gene silencing, and genomic stability.
Figure 2. Mechanisms of action of resveratrol on silent information regulator 2 type 1 (SIRT1). Following a stressful event, resveratrol activates SIRT1 that binds different genes such as NF-kB, FOXO4, HIF 2 alpha, FOXO1, FOXO3, NBS1, and PGC-1 alpha. The activation of these genes is correlated with regulation of energy homeostasis, cell survival, gene silencing, and genomic stability.
Molecules 25 04554 g002
Molecules 25 04554 g003 550
Figure 3. Mechanism of action of resveratrol in spermatozoa. Resveratrol activates the AMPK pathway, which is correlated with a higher mitochondrial function and higher activity of Glutathione (GSH), glutathione peroxidase (GPx), Superoxide dismutase (SOD), and catalase determining ROS equilibrium. These mechanisms protect against oxidative stress, ameliorating sperm quality and, thereby, fertility of the spermatozoa.
Figure 3. Mechanism of action of resveratrol in spermatozoa. Resveratrol activates the AMPK pathway, which is correlated with a higher mitochondrial function and higher activity of Glutathione (GSH), glutathione peroxidase (GPx), Superoxide dismutase (SOD), and catalase determining ROS equilibrium. These mechanisms protect against oxidative stress, ameliorating sperm quality and, thereby, fertility of the spermatozoa.
Molecules 25 04554 g003

Share and Cite

MDPI and ACS Style

Pasquariello, R.; Verdile, N.; Brevini, T.A.L.; Gandolfi, F.; Boiti, C.; Zerani, M.; Maranesi, M. The Role of Resveratrol in Mammalian Reproduction. Molecules 2020, 25, 4554. https://doi.org/10.3390/molecules25194554

AMA Style

Pasquariello R, Verdile N, Brevini TAL, Gandolfi F, Boiti C, Zerani M, Maranesi M. The Role of Resveratrol in Mammalian Reproduction. Molecules. 2020; 25(19):4554. https://doi.org/10.3390/molecules25194554

Chicago/Turabian Style

Pasquariello, Rolando, Nicole Verdile, Tiziana A. L. Brevini, Fulvio Gandolfi, Cristiano Boiti, Massimo Zerani, and Margherita Maranesi. 2020. "The Role of Resveratrol in Mammalian Reproduction" Molecules 25, no. 19: 4554. https://doi.org/10.3390/molecules25194554

Article Metrics

Back to TopTop